Taro Pharmaceutical ...
NYSE:TARO
$ 42,97
$0,00 (0,00%)
42,97 $
$0,00 (0,00%)
End-of-day quote: 06/21/2024

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

This stock is no longer listed on the stock exchange.

$1,77
Earnings Per Share
$16,74
Revenue Per Share
48,47%
Gross Margin %
$1,62 B
Market Cap
$0,01 B
Long-Term Debt
Earnings Per Share
$1,77
Revenue Per Share
$16,74
Gross Margin %
48,47%
Market Cap
$1,62 B
Long-Term Debt
$0,01 B

Financials

Year Year 2024 2023 2022 2020 2019 2018 2017 2016 2015 2014 2013 2009 2008 2007
EPS Earnings Per Share $0,00 $1,77 $0,68 $2,77 $6,35 $7,15 $6,22 $11,26 $12,69 $11,24 $8,19 $6,57 $1,09 $1,27 $0,60
Earnings Earnings $0,00M $66,52M $25,55M $104,10M $242,95M $275,56M $245,25M $456,14M $542,75M $481,41M $350,78M $294,14M $42,78M $49,78M $23,52M
RPS Revenue Per Share $16,74 $15,25 $14,94 $16,85 $17,38 $16,79 $21,71 $22,23 $20,15 $17,73 $0,00 $0,00 $0,00 $0,00
Revenue Revenue $629,18M $572,95M $561,35M $644,77M $669,89M $661,91M $879,39M $950,75M $862,94M $759,29M $0,00M $0,00M $0,00M $0,00M
OCF Operating Cash Flow $0,00M $0,00M $0,00M $0,00M $0,00M $323,69M $0,00M $0,00M $0,00M $357,64M $0,00M $0,00M $0,00M $0,00M
FCF Free Cash Flow $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $336,40M $0,00M $0,00M $0,00M $0,00M
OM Operating Margin 1,16% 3,09% 22,25% 38,24% 43,67% 46,06% 58,59% 64,95% 60,66% 57,01% 53,94% 0,00% 0,00% 0,00%
GM % Gross Margin % 48,47% 46,83% 52,22% 62,00% 66,54% 70,03% 76,36% 82,15% 78,40% 76,39% 73,75% 0,00% 0,00% 0,00%
FCFS Free Cash Flow Per Share $1,87 $0,37 $-4,54 $6,32 $7,52 $7,33 $9,73 $8,78 $9,03 $7,49 $5,34 $0,00 $0,00 $0,00
LT Debt Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A $5,63M $6,69M $18,48M $39,23M $59,67M $76,79M
Sha. Stocks 37,58M 37,58M 37,58M 38,26M 38,54M 39,43M 40,51M 42,77M 42,83M 42,83M 44,77M 39,25M 39,2M 39,2M
×